EP3666202A1 - Systems and methods for embolic implant detachment - Google Patents
Systems and methods for embolic implant detachment Download PDFInfo
- Publication number
- EP3666202A1 EP3666202A1 EP19215318.7A EP19215318A EP3666202A1 EP 3666202 A1 EP3666202 A1 EP 3666202A1 EP 19215318 A EP19215318 A EP 19215318A EP 3666202 A1 EP3666202 A1 EP 3666202A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- delivery tube
- introducer sheath
- interference feature
- proximal end
- length
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003073 embolic effect Effects 0.000 title claims abstract description 114
- 239000007943 implant Substances 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims description 33
- 206010002329 Aneurysm Diseases 0.000 claims abstract description 8
- 238000002513 implantation Methods 0.000 claims description 46
- 239000000463 material Substances 0.000 description 5
- 238000004513 sizing Methods 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M2025/0079—Separate user-activated means, e.g. guidewires, guide tubes, balloon catheters or sheaths, for sealing off an orifice, e.g. a lumen or side holes, of a catheter
Definitions
- the present invention generally relates to aneurysm treatment devices and more particularly, to delivery systems for embolic implants.
- Implant devices are known in the field. Many are deployed mechanically, via systems that combine one or more catheters and wires for delivery. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures delivered through a microcatheter. Some obstetric and gastrointestinal implants may also be implanted via similar systems that combine one or more catheters and wires. Devices that may be released or deployed by mechanical means vary greatly in design but can employ a similar delivery catheter and wire system. Many such catheter-based delivery systems include a wire for retention of the implant in the catheter until the time for release of the device. These systems are then actuated by retracting or pulling the wire relative to the catheter. Such a wire is referred to herein as a "pull wire".
- a physician can use one of many known deployment apparatuses.
- Such mechanical deployment apparatuses are typically separate from the delivery system and have moving parts for gripping the pull wire and for moving the pull wire proximally.
- Deployment methods and apparatuses that do not require auxiliary components and/or complex moving parts can simplify treatment procedures and reduce cost. There is therefore a need for simplified mechanical implant deployment apparatuses.
- Examples can generally include an embolic implantation system that includes an embolic implant, a delivery system, and an introducer sheath that are collectively designed so that the combination of the introducer sheath and the delivery system can be used as a deployment apparatus for the embolic implant.
- the delivery system can have a pull wire, a delivery tube, and an interference feature attached to the pull wire and positioned at a proximal end of the delivery tube.
- the introducer sheath can be moved proximally over the delivery tube until it engages the interference feature.
- the introducer sheath can be pressed against the interference feature, causing the interference feature to move proximally in relation to the delivery tube, thereby proximally pulling the pull wire to which the interference feature is attached and deploying the implant.
- An example implantation system can include a delivery tube, an embolic coil, an introducer sheath, an interference feature, and an elongated member.
- the embolic coil can be detachably attached to a distal end of the delivery tube.
- the interference feature can be positioned at a proximal end of the delivery tube and movable in relation to the delivery tube.
- the elongated member can be positioned within a lumen of the delivery tube and attached to the interference feature.
- the introducer sheath can have a lumen sized to slidably receive the delivery tube and the embolic coil, the introducer sheath can be translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube, and the introducer sheath can be sized to engage the interference feature.
- the interference feature can be movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature.
- the elongated member can be movable in relation to the delivery tube in response to a proximal movement of the interference feature.
- the interference feature can be detachable from the delivery tube.
- the elongated member can be movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
- the delivery tube can have a soft section near the distal end of the delivery tube.
- the length of the embolic coil and the soft section as measured from a distal end of the un-implanted embolic coil to a proximal end of the soft section can be shorter than the end-to-end length of the introducer sheath so that the introducer sheath is sized to fully encompass the un-implanted embolic coil and the soft section.
- the introducer sheath can be longer than the length of the embolic coil and soft section by about 5 cm.
- the system can include a microcatheter, and the delivery tube can have an end-to-end length that is longer than the sum of the end-to-end length of the introducer sheath and an end-to-end length of the microcatheter.
- the end-to-end length of the introducer sheath can be between about 46 cm to about 105 cm.
- the introducer sheath can be movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.
- the embolic coil can be detached from the delivery tube by moving the elongated member proximally in relation to the delivery tube.
- the interference feature can have a substantially circular surface positioned to engage the proximal end of the introducer sheath.
- a distal end of the introducer sheath can be sized to engage a microcatheter to create an enclosed interface through which the embolic coil and at least a portion of the delivery tube can pass.
- An example implantation assembly can include a delivery tube, an embolic implant, a pull wire, an engagement bump, and a tubular sheath.
- the embolic implant can be attached to a distal end of the delivery tube.
- the pull wire can be disposed within a lumen of the delivery tube and movable to detach the embolic implant from the delivery tube.
- the engagement bump can be disposed on a proximal end of the pull wire and positioned near a proximal end of the delivery tube.
- the tubular sheath can be conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, and the tubular sheath can be sized to engage the engagement bump.
- the engagement bump and the pull wire can be movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.
- the delivery tube can have a soft section extending proximally from the distal end of the delivery tube, and the tubular sheath can measure end-to-end about 5 cm longer than a length measured from a distal end of the embolic implant to a proximal end of the soft section when the embolic implant is attached to the delivery tube and extended in an un-implanted configuration.
- the assembly can include a microcatheter, and the delivery tube can have an end-to-end length that is greater than the sum of the length of the introducer sheath and the microcatheter.
- the tubular sheath can be movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump.
- the engagement bump can be detachable from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.
- the pull wire can be movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.
- An example method for treating an aneurysm can include the steps of providing an implantation system including an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire; affixing the pull wire to the interference feature; positioning the pull wire within a lumen of the delivery tube; attaching the interference feature to a proximal end of the delivery tube; attaching the embolic implant at a distal end of the delivery tube; positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube; sliding the introducer sheath proximally over the delivery tube; pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
- the first portion of the delivery tube over which the introducer sheath is positioned in the example method can have a soft section.
- the method can include sizing the introducer sheath to have a length that is greater than the length of the embolic implant and the soft section by about 5 cm.
- the method can include sizing the introducer sheath to have a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
- the method can include detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
- the method can include detaching the interference feature from the delivery tube.
- the interference feature can be detached in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
- the method can include providing a microcatheter; positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.
- Examples presented herein utilize an introducer sheath to facilitate mechanical deployment of an implant.
- implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures deliverable through a microcatheter.
- Some implants are currently packaged with an introducer sheath that is removed from the device and discarded near the beginning of an implantation procedure.
- embolic coils and other embolic implants can be used to occlude vessels in a variety of medical applications.
- the embolic implant is contained in an introducer sheath.
- the introducer sheath In present treatment practices, once the embolic implant is transferred to a microcatheter, the introducer sheath would be removed from the delivery system and discarded before the embolic implant reaches a treatment site.
- the introducer sheath can be slid proximally and can facilitate deployment of the embolic implant, i.e. detachment of the embolic implant from the delivery system.
- the delivery system can have an interference feature positioned at a proximal end of a delivery tube and attached to a pull wire, and the combination of the introducer sheath, delivery tube, pull wire, and interference feature can be configured such that the introducer sheath can engage with the interference feature and move the interference feature proximally in relation to the delivery tube, thereby pulling the pull wire proximally and deploying the embolic implant.
- the delivery tube, microcatheter, and introducer sheath can each have a respective length sized such that the introducer sheath can be long enough to cover the embolic implant and sensitive portions of the delivery system, and the delivery tube can be long enough to extend through the entire length of the microcatheter and the entire length of the introducer sheath.
- FIG. 1 is an illustration of an exemplary implantation system 100.
- the implantation system 100 can have an embolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac, a delivery tube 110 for delivering the embolic implant 140 to a treatment site, a pull wire 130 disposed within the delivery tube that can be pulled proximally to deploy the embolic implant 140, an interference feature 120 positioned at a proximal end 112 of the delivery tube 110 attached to the pull wire 130 that can be pulled proximally to pull the pull wire 130 proximally, and an introducer sheath 180 that can be moved proximally to engage the interference feature 120 and pull the interference feature 120 proximally.
- an embolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac
- a delivery tube 110 for delivering the embolic implant 140 to a treatment site
- a pull wire 130 disposed within the delivery tube
- the introducer sheath 180 can have a lumen therethrough that is sized to slidably receive the delivery tube 110 and the embolic implant 140.
- the introducer sheath 180 can be sized such that it can be translated proximally from the position illustrated in FIG. 1 over a length of the delivery tube 110 to engage the interference feature 120 positioned at the proximal end 112 of the delivery tube 110.
- the interference feature 120 can be movable in relation to the delivery tube 110.
- the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the system 100 can include a disconnection feature 122 that can be unhooked, torn, broken, twisted, or otherwise manipulated to disconnect the interference feature 120 from the delivery tube 110.
- the delivery tube 110 can have a soft section 116 positioned near a distal end 114 of the delivery tube 110 that has a greater flexibility than the remainder (proximal portion) 118 of the delivery tube 110.
- the embolic implant 140 can be detachably attached to a distal end 114 of the delivery tube 114.
- the soft section 116 can be designed to allow greater control and stability of the distal end 114 of the delivery tube 110 during implantation and deployment of the embolic implant 140.
- the soft section 116 can have laser cut notches or groves, and/or the soft section 116 can be made of a more flexible material compared to the remainder 118 of the delivery tube 110.
- the introducer sheath 180 can serve the purpose of protecting (packaging) the embolic implant 140 and the soft section 116 of the delivery tube 110 as the system 100 is being handled prior to, and at the beginning of a patient treatment procedure. For this purpose, it is therefore desirable for the introducer sheath 180 to be long enough to completely encompass the embolic implant 140 and the soft section 116 prior to the treatment procedure.
- the combined length of the embolic implant 140 and the soft section 116 can be measured from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116.
- the introducer sheath 180 can have a length measurable from a distal end 184 to a proximal end 182 of the introducer sheath that can be sized a few centimeters longer than the combined length of the embolic implant 140 and the soft section 116 to ensure that the embolic implant 140 and soft section 116 remain protected in case portions of the system 100 shift during handling prior to the treatment procedure.
- the introducer sheath 180 can have a length that is about 5 cm longer than the combined length of the embolic implant 140 and the soft section 116.
- the embolic implant 140 can have a length of between about 1 cm and about 60 cm, the soft section 116 can have a length of about 40 cm, and the introducer sheath can have a length that is about 5 cm longer than the sum of the embolic implant 140 length and the soft section 116 length, i.e. between about 46 cm and about 105 cm.
- FIGs. 2A and 2B are illustrations of an exemplary implantation system such as illustrated in FIG. 1 interfacing with a microcatheter 200.
- FIG. 2A illustrates an instant of a treatment procedure near the beginning of the treatment procedure in which an introducer sheath 180 is positioned to cover an embolic implant 140 and a soft portion 116 of a delivery tube 110 in a packaged configuration and a distal end 184 of the introducer sheath 180 is mated or engaged with a proximal end of the microcatheter 200. As shown in FIG.
- the distal end 184 of the introducer sheath 180 can be sized to engage the microcatheter 200 to create an enclosed interface through which the embolic implant 140 and the soft portion 116 of the delivery tube 110 can pass.
- the embolic implant 140 and the delivery tube 110 can be translated distally to push the embolic implant 140 and a portion of the delivery tube 110 into the microcatheter 200.
- FIG. 2B illustrates an instant of the treatment procedure in which the embolic implant 140 and the soft portion 116 are positioned within the microcatheter 200.
- the embolic implant 140 and the soft portion 116 are protected by the microcatheter 200 and the introducer sheath can now be pulled proximally 180 or left in place as the delivery tube 110 and embolic implant 140 are further translated distally.
- FIGs. 3A through 3C are illustrations of an exemplary implantation system during a series of example implantation steps.
- FIG. 3A illustrates an embolic implant 140 and a soft portion 116 of a delivery tube 110 positioned inside a microcatheter 200 and an introducer sheath 180 being translated proximally over a proximal portion 118 of the delivery tube 110.
- the introducer sheath 180 can be disengaged from the microcatheter 200 and pulled proximally once the embolic implant 140 and soft section 116 are protected within the microcatheter 200, but before the embolic implant 140 is positioned at a treatment site or within an aneurysm.
- the introducer sheath 180 can remain engaged to the microcatheter until the embolic implant 140 is positioned at the treatment site or ready to be deployed from the delivery tube 110 and then pulled proximally after the embolic implant 140 is positioned at the treatment site.
- FIG. 3B illustrates the introducer sheath 180 in a deployment configuration in which the introducer sheath 180 is engaged with an interference feature 120 positioned near a proximal end 112 of the delivery tube 110.
- the introducer sheath 180 is shown providing a force F against the interference feature 120.
- the force can be sufficient to move the interference feature 120 proximally in relation to the delivery tube 110.
- the interference feature 120 Prior to the application of the force F, the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the interference feature 120 can be detached from the proximal end 112 of the delivery tube 110 in response to the force F.
- the interference feature 120 can remain attached to the delivery tube 110 and the force F can be sufficient to move the interference feature 120 in relation to the delivery tube 110.
- the introducer sheath 180 can be sized to engage the interference feature 120.
- the introducer sheath 180 can be tubular and can have a circular proximal end 182, and the interference feature 120 can protrude radially beyond a circumference of the delivery tube 110.
- the interference feature 120 can be circular, having a circumference larger than a circumference of the proximal end 182 of the introducer sheath 180.
- the interference feature 120 can provide a flat surface against which the proximal end 182 of the introducer sheath 180 can press. Additionally, or alternatively, the interference feature can have a non-flat surface that can have a slope or a groove for receiving the introducer sheath 180.
- the interference feature 120 can be a bump positioned near the distal end of the delivery tube that extends beyond the circumference of the delivery tube and extends so that the introducer sheath 180, when slid proximally over the delivery tube 110, must engage the interreference feature 120 before sliding completely over and off the proximal end 112 of the delivery tube 110.
- FIG. 3C illustrates the interference feature 120 after being moved proximally in relation to the delivery tube 110 in response to the force F from the introducer sheath 180.
- the interference feature 120 can be attached to a pull wire 130, and the pull wire 130 can be pulled proximally when the interference feature 180 is moved proximally.
- the interference feature 120 can be detachably attached to the delivery tube 110 prior to the proximal movement of the interference feature 120, and a detachment feature 122 can be manipulated to facilitate the detachment of the interference feature 120.
- the interference feature 120 can be pulled proximally away from the delivery tube 110, and the pull wire 130 can be moved to exit the proximal end 112 of the delivery tube 110 in response to the pulling of the interference feature 120.
- the pull wire 130 can be an elongated member that extends through a lumen of the delivery tube 110 toward the embolic implant 140.
- the pull wire 130 can constitute a component of a deployment system for releasing the embolic implant 140 at the distal end 114 of the delivery tube 110.
- the pull wire 130 can initiate the deployment of the embolic implant 140.
- the embolic implant 140 can be detached from the delivery tube 110 in response to the proximal movement of the pull wire 130 in relation to the delivery tube 110.
- FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature 122a.
- the implantation system can have an interference feature 120 detachably attached to a delivery tube 110 by the breakable disconnection feature 122a.
- the delivery tube 110 can include notches 115 that are areas in which material is removed from the delivery tube 110.
- the notches 115 can be positioned at a proximal end 112 of the delivery tube 110.
- the proximal end 112 of the delivery tube 110 can be attached to the interference feature 120 by gluing, welding, or other means.
- the notches 115 can be a breakable section 122a of the delivery tube 110.
- FIG. 4B is a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 4A .
- FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature 122b.
- the implantation system can have a delivery tube 110 with groove 113 cut at a proximal end 112 and an interference feature 120 that has a bump 123 or another feature that can engage the groove 113.
- the interference feature 120 can be detachably attached to the delivery tube 110 by the twist-lock disconnection feature (and/or a bayonet connector) 122b.
- the interference feature 120 can extend within a lumen of the delivery tube 110 at the proximal end 112 of the delivery tube 110 and have a bump or protrusion 123 that can be positioned in the groove 113 in the delivery tube 110 to maintain the attachment between the interference feature 120 and the delivery tube 110.
- FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 5A .
- FIGs. 4A through 5B illustrate examples of an interference feature 120 that is movable in relation to the delivery tube 110 after detaching from the delivery tube 110
- the interference feature need not be detached, and can be movable in relation to the delivery tube 110 without detaching.
- FIGs. 6A through 8C illustrate example systems wherein the interference feature 120 remains at least partially attached to the delivery tube 110.
- FIG. 6A illustrates an exemplary implantation system having a sliding track 113a and a bump or protrusion 123a.
- the sliding track 113a can be cut from a portion of the delivery tube 110 near the proximal end 112 of the delivery tube 110.
- the interference feature 120 can have an engagement bump or protrusion 123a that is positioned to slide within the track 113a.
- the track 113a can extend along a portion of a length of the delivery tube 110, and the bump 123a can slide within the track 113a, allowing the interference feature 120 to move in a proximal direction in relation to the delivery tube 110.
- the track 113a can be L shaped, and the interference feature 120 can be twisted in relation to the delivery tube 110 and then pulled proximally in relation to the delivery tube 110 to move the interference feature 120 in relation to the delivery tube 110.
- the interference feature 120 can be attached to a pull wire 130, and the movement of the interference feature 120 can move the pull wire 130 to deploy an embolic implant 140.
- FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 6A .
- FIG. 7A illustrates an exemplary implantation system having a stretchable segment 126.
- the implantation system can have a delivery tube 110 with a stretchable segment 126 positioned near a proximal end 112 of the delivery tube 110.
- the stretchable segment 126 can be a region of the delivery tube 110 that has a propensity to stretch in response to a force that creates tension along a length of the delivery tube 110 that includes the stretchable segment 126.
- the stretchable segment 126 can include a coil that is compressed in an initial state as illustrated in FIG. 7A , a laser cut portion of the tube, and/or a portion of tubing having greater elasticity.
- the stretchable segment 126 can extends in response to a force provided by the introducer sheath 180 against the interference feature 120.
- the stretchable segment 126 can allow the pull wire and the interference feature 120 to move proximally in relation to the delivery tube 110 without the interference feature 120 becoming disconnected from the delivery tube 110.
- the stretchable segment 126 can have a fully extended length that is determined by the material properties and/or construction of the stretchable segment 126. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110.
- FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 7A .
- FIGs. 8A through 8C illustrate an exemplary implantation system having a stretchable element 126a and a detachment feature 122c.
- the disconnection feature 122c illustrated in FIGs. 8A through 8C can include notches 115B in a delivery tube 110, similar to that illustrated in FIGs. 4 and 4B . It is contemplated that other disconnection features, including the disconnection features illustrated in, and described in relation to FIGs. 1 , 3A-3C , 5, or 5B could be combined with a stretchable segment like those described herein or otherwise known.
- the disconnection feature 122c can be positioned along a length of the delivery tube 110 at or near the stretchable segment 126a. Both the stretchable segment 126a and the disconnection feature 122c can be positioned near the proximal end 112 of the delivery tube 110.
- FIG. 8A illustrates the stretchable element 126a positioned within a lumen of the delivery tube 110 near the proximal end 112 of the delivery tube 110.
- the delivery tube 110 is illustrated cut-away to show coils of the stretchable element 126a within.
- interference feature 120 can be attached to the delivery tube 110 via the stretchable element 126a and the detachment feature 122c.
- FIG. 8B illustrates an introducer sheath 180 moved proximally to engage the interference feature 120, break the detachment feature 122c, and begin to stretch the stretchable element 126a.
- the delivery tube 110 and the introducer sheath 180 are shown cut-away.
- a pull wire 130 can be positioned within the delivery tube 110. The pull wire 130 can be pulled proximally as the interference feature 120 is moved proximally.
- the stretchable element 126a can be attached to the interference feature 120 with a weld, adhesive, or other connection 125.
- the stretchable element 126a can be attached to the delivery tube 110 with a weld, adhesive, or other connection 127. After the detachment feature 122c is detached, the stretchable element 126a can maintain an attachment between the interference feature 120 and the delivery tube 110.
- FIG. 8C illustrates the introducer sheath 180 moved further proximally to move the interference feature 120 and pull wire 130 further proximally and further stretch the stretchable element 126a.
- the stretchable element 126a can have a fully extended length that is determined by the material properties and/or construction of the stretchable element 126a. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110.
- FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art.
- Known delivery systems are typically 200 cm long, known microcatheters are typically 165 cm long, and known introducer sheaths are typically 130 cm long.
- the introducer sheath is typically removed after an embolic implant and any sensitive portions of the delivery system are inserted into the microcatheter. According to known practices, an introducer sheath cannot remain around the delivery system during the deployment step of the embolic implant because the combined length of known microcatheters and introducers is several centimeters longer than known delivery systems.
- an implantation system can include a delivery system, microcatheter, and introducer sheath, wherein the delivery system is longer than the combined length of the microcatheter and the introducer sheath.
- An aneurysm can be treated with an implantation system such as any of the implantation systems disclosed herein in relation to the present invention by executing some or all the following steps, not necessarily in order.
- An implantation system 100 having an embolic implant 140, an introducer sheath 180, a delivery tube 110, an interference feature 120, and a pull wire 130 can be provided.
- the pull wire 130 can be affixed to the interference feature 120.
- the pull wire 130 can be positioned within a lumen of the delivery tube 110.
- the interference feature 120 can be attached to a proximal end 112 of the delivery tube 110.
- the embolic implant 140 can be attached at a distal end 114 of the delivery tube 110.
- the introducer sheath 180 can be positioned to encompass the embolic implant 140 and a first portion of the delivery tube 110.
- the first portion of the delivery tube 110 can comprise a soft section 116.
- the introducer sheath can be sized to have an end-to-end length that is longer by about 5 cm than a length measurable from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116.
- the introducer sheath 180 can be sized so that the end-to-end length is between about 46 cm and about 105 cm.
- a microcatheter 200 can be provided.
- the introducer sheath 180 can be positioned to engage with the microcatheter 200 while maintaining the embolic implant 140 and the first portion of the delivery tube 110 within the introducer sheath 180.
- the embolic implant 140 and the delivery tube 110 can be translated distally to position the embolic implant 140 and the first portion of the delivery tube 110 within the microcatheter 200.
- the introducer sheath 180 can be slid proximally over the delivery tube 110.
- the introducer sheath 180 can be pulled proximally to apply a force from the introducer sheath 180 to the interference feature 120.
- the interference feature 120 and the pull wire 130 can be moved proximally in relation to the delivery tube 110 in response to the force.
- the interference feature 120 can be detached from the delivery tube 110.
- the embolic implant 140 can be detached from the delivery tube 110 in response to moving the interference feature 120 and the pull wire 130 proximally in relation to the delivery tube 110.
- the methods described herein may be not methods for the treatment of the human or animal body by surgery or therapy.
- the methods may be ex vivo and/or in vitro methods e.g. methods taking place in a laboratory and/or for testing.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
- The present invention generally relates to aneurysm treatment devices and more particularly, to delivery systems for embolic implants.
- Numerous intravascular implant devices are known in the field. Many are deployed mechanically, via systems that combine one or more catheters and wires for delivery. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures delivered through a microcatheter. Some obstetric and gastrointestinal implants may also be implanted via similar systems that combine one or more catheters and wires. Devices that may be released or deployed by mechanical means vary greatly in design but can employ a similar delivery catheter and wire system. Many such catheter-based delivery systems include a wire for retention of the implant in the catheter until the time for release of the device. These systems are then actuated by retracting or pulling the wire relative to the catheter. Such a wire is referred to herein as a "pull wire".
- To pull the pull wire proximally to deploy the implant, a physician can use one of many known deployment apparatuses. Such mechanical deployment apparatuses are typically separate from the delivery system and have moving parts for gripping the pull wire and for moving the pull wire proximally. Deployment methods and apparatuses that do not require auxiliary components and/or complex moving parts can simplify treatment procedures and reduce cost. There is therefore a need for simplified mechanical implant deployment apparatuses.
- Disclosed herein are various exemplary systems, devices, and methods of the present invention that can address the above needs. Examples can generally include an embolic implantation system that includes an embolic implant, a delivery system, and an introducer sheath that are collectively designed so that the combination of the introducer sheath and the delivery system can be used as a deployment apparatus for the embolic implant. The delivery system can have a pull wire, a delivery tube, and an interference feature attached to the pull wire and positioned at a proximal end of the delivery tube. The introducer sheath can be moved proximally over the delivery tube until it engages the interference feature. To deploy the implant, the introducer sheath can be pressed against the interference feature, causing the interference feature to move proximally in relation to the delivery tube, thereby proximally pulling the pull wire to which the interference feature is attached and deploying the implant.
- An example implantation system can include a delivery tube, an embolic coil, an introducer sheath, an interference feature, and an elongated member. The embolic coil can be detachably attached to a distal end of the delivery tube. The interference feature can be positioned at a proximal end of the delivery tube and movable in relation to the delivery tube. The elongated member can be positioned within a lumen of the delivery tube and attached to the interference feature. The introducer sheath can have a lumen sized to slidably receive the delivery tube and the embolic coil, the introducer sheath can be translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube, and the introducer sheath can be sized to engage the interference feature. The interference feature can be movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature. The elongated member can be movable in relation to the delivery tube in response to a proximal movement of the interference feature.
- The interference feature can be detachable from the delivery tube. The elongated member can be movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
- The delivery tube can have a soft section near the distal end of the delivery tube. The length of the embolic coil and the soft section as measured from a distal end of the un-implanted embolic coil to a proximal end of the soft section can be shorter than the end-to-end length of the introducer sheath so that the introducer sheath is sized to fully encompass the un-implanted embolic coil and the soft section. The introducer sheath can be longer than the length of the embolic coil and soft section by about 5 cm.
- The system can include a microcatheter, and the delivery tube can have an end-to-end length that is longer than the sum of the end-to-end length of the introducer sheath and an end-to-end length of the microcatheter.
- The end-to-end length of the introducer sheath can be between about 46 cm to about 105 cm.
- The introducer sheath can be movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.
- The embolic coil can be detached from the delivery tube by moving the elongated member proximally in relation to the delivery tube.
- The interference feature can have a substantially circular surface positioned to engage the proximal end of the introducer sheath.
- A distal end of the introducer sheath can be sized to engage a microcatheter to create an enclosed interface through which the embolic coil and at least a portion of the delivery tube can pass.
- An example implantation assembly can include a delivery tube, an embolic implant, a pull wire, an engagement bump, and a tubular sheath. The embolic implant can be attached to a distal end of the delivery tube. The pull wire can be disposed within a lumen of the delivery tube and movable to detach the embolic implant from the delivery tube. The engagement bump can be disposed on a proximal end of the pull wire and positioned near a proximal end of the delivery tube. The tubular sheath can be conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, and the tubular sheath can be sized to engage the engagement bump. The engagement bump and the pull wire can be movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.
- The delivery tube can have a soft section extending proximally from the distal end of the delivery tube, and the tubular sheath can measure end-to-end about 5 cm longer than a length measured from a distal end of the embolic implant to a proximal end of the soft section when the embolic implant is attached to the delivery tube and extended in an un-implanted configuration.
- The assembly can include a microcatheter, and the delivery tube can have an end-to-end length that is greater than the sum of the length of the introducer sheath and the microcatheter.
- The tubular sheath can be movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump.
- The engagement bump can be detachable from the delivery tube in response to the force applied by the tubular sheath to the engagement bump. The pull wire can be movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.
- An example method for treating an aneurysm can include the steps of providing an implantation system including an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire; affixing the pull wire to the interference feature; positioning the pull wire within a lumen of the delivery tube; attaching the interference feature to a proximal end of the delivery tube; attaching the embolic implant at a distal end of the delivery tube; positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube; sliding the introducer sheath proximally over the delivery tube; pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
- The first portion of the delivery tube over which the introducer sheath is positioned in the example method can have a soft section. The method can include sizing the introducer sheath to have a length that is greater than the length of the embolic implant and the soft section by about 5 cm. The method can include sizing the introducer sheath to have a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
- The method can include detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube. The method can include detaching the interference feature from the delivery tube. The interference feature can be detached in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
- The method can include providing a microcatheter; positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.
- The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
-
FIG. 1 is an illustration of an exemplary implantation system according to aspects of the present invention; -
FIGs. 2A and 2B are illustrations of an exemplary implantation system such as illustrated inFIG. 1 interfacing with a microcatheter according to aspects of the present invention; -
FIGs. 3A through 3C are illustrations of implantation steps that can be performed with an exemplary implantation system such as illustrated inFIG. 1 according to aspects of the present invention; -
FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature according to aspects of the present invention; -
FIG. 4B illustrates a cross-sectional view near a proximal end of the exemplary implantation system ofFIG. 4A as indicated inFIG. 4A and according to aspects of the present invention; -
FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature according to aspects of the present invention; -
FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system ofFIG. 5A as indicated inFIG. 5A and according to aspects of the present invention; -
FIG. 6A illustrates an exemplary implantation system having a sliding track according to aspects of the present invention; -
FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system ofFIG. 6A as indicated inFIG. 6A and according to aspects of the present invention; -
FIG. 7A illustrates an exemplary implantation system having a stretchable segment according to aspects of the present invention; -
FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system ofFIG. 7A as indicated inFIG. 7A and according to aspects of the present invention; -
FIGs. 8A through 8C illustrate cut-away views of an exemplary implantation system having a stretchable segment and a disconnecting feature according to aspects of the present invention; and -
FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art. - Examples presented herein utilize an introducer sheath to facilitate mechanical deployment of an implant. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures deliverable through a microcatheter. Some implants are currently packaged with an introducer sheath that is removed from the device and discarded near the beginning of an implantation procedure. For example, in existing systems, embolic coils and other embolic implants can be used to occlude vessels in a variety of medical applications. In many instances, prior to implantation and during handling of an embolic implant outside of a patient, the embolic implant is contained in an introducer sheath. In present treatment practices, once the embolic implant is transferred to a microcatheter, the introducer sheath would be removed from the delivery system and discarded before the embolic implant reaches a treatment site. In examples presented herein, according to the present invention, rather than being discarded, the introducer sheath can be slid proximally and can facilitate deployment of the embolic implant, i.e. detachment of the embolic implant from the delivery system. In order to use the introducer sheath to facilitate deployment, the delivery system can have an interference feature positioned at a proximal end of a delivery tube and attached to a pull wire, and the combination of the introducer sheath, delivery tube, pull wire, and interference feature can be configured such that the introducer sheath can engage with the interference feature and move the interference feature proximally in relation to the delivery tube, thereby pulling the pull wire proximally and deploying the embolic implant. The delivery tube, microcatheter, and introducer sheath can each have a respective length sized such that the introducer sheath can be long enough to cover the embolic implant and sensitive portions of the delivery system, and the delivery tube can be long enough to extend through the entire length of the microcatheter and the entire length of the introducer sheath.
-
FIG. 1 is an illustration of an exemplary implantation system 100. The implantation system 100 can have anembolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac, adelivery tube 110 for delivering theembolic implant 140 to a treatment site, apull wire 130 disposed within the delivery tube that can be pulled proximally to deploy theembolic implant 140, aninterference feature 120 positioned at aproximal end 112 of thedelivery tube 110 attached to thepull wire 130 that can be pulled proximally to pull thepull wire 130 proximally, and anintroducer sheath 180 that can be moved proximally to engage theinterference feature 120 and pull theinterference feature 120 proximally. - The
introducer sheath 180 can have a lumen therethrough that is sized to slidably receive thedelivery tube 110 and theembolic implant 140. Theintroducer sheath 180 can be sized such that it can be translated proximally from the position illustrated inFIG. 1 over a length of thedelivery tube 110 to engage theinterference feature 120 positioned at theproximal end 112 of thedelivery tube 110. - The interference feature 120 can be movable in relation to the
delivery tube 110. For example, theinterference feature 120 can be detachably attached to theproximal end 112 of thedelivery tube 110, and the system 100 can include adisconnection feature 122 that can be unhooked, torn, broken, twisted, or otherwise manipulated to disconnect the interference feature 120 from thedelivery tube 110. - The
delivery tube 110 can have asoft section 116 positioned near adistal end 114 of thedelivery tube 110 that has a greater flexibility than the remainder (proximal portion) 118 of thedelivery tube 110. Theembolic implant 140 can be detachably attached to adistal end 114 of thedelivery tube 114. Thesoft section 116 can be designed to allow greater control and stability of thedistal end 114 of thedelivery tube 110 during implantation and deployment of theembolic implant 140. Thesoft section 116 can have laser cut notches or groves, and/or thesoft section 116 can be made of a more flexible material compared to theremainder 118 of thedelivery tube 110. - The
introducer sheath 180 can serve the purpose of protecting (packaging) theembolic implant 140 and thesoft section 116 of thedelivery tube 110 as the system 100 is being handled prior to, and at the beginning of a patient treatment procedure. For this purpose, it is therefore desirable for theintroducer sheath 180 to be long enough to completely encompass theembolic implant 140 and thesoft section 116 prior to the treatment procedure. The combined length of theembolic implant 140 and thesoft section 116 can be measured from adistal end 144 of theembolic implant 140 to aproximal end 117 of thesoft section 116. Theintroducer sheath 180 can have a length measurable from adistal end 184 to aproximal end 182 of the introducer sheath that can be sized a few centimeters longer than the combined length of theembolic implant 140 and thesoft section 116 to ensure that theembolic implant 140 andsoft section 116 remain protected in case portions of the system 100 shift during handling prior to the treatment procedure. Theintroducer sheath 180 can have a length that is about 5 cm longer than the combined length of theembolic implant 140 and thesoft section 116. For example, theembolic implant 140 can have a length of between about 1 cm and about 60 cm, thesoft section 116 can have a length of about 40 cm, and the introducer sheath can have a length that is about 5 cm longer than the sum of theembolic implant 140 length and thesoft section 116 length, i.e. between about 46 cm and about 105 cm. -
FIGs. 2A and 2B are illustrations of an exemplary implantation system such as illustrated inFIG. 1 interfacing with amicrocatheter 200.FIG. 2A illustrates an instant of a treatment procedure near the beginning of the treatment procedure in which anintroducer sheath 180 is positioned to cover anembolic implant 140 and asoft portion 116 of adelivery tube 110 in a packaged configuration and adistal end 184 of theintroducer sheath 180 is mated or engaged with a proximal end of themicrocatheter 200. As shown inFIG. 2A , thedistal end 184 of theintroducer sheath 180 can be sized to engage themicrocatheter 200 to create an enclosed interface through which theembolic implant 140 and thesoft portion 116 of thedelivery tube 110 can pass. Theembolic implant 140 and thedelivery tube 110 can be translated distally to push theembolic implant 140 and a portion of thedelivery tube 110 into themicrocatheter 200. -
FIG. 2B illustrates an instant of the treatment procedure in which theembolic implant 140 and thesoft portion 116 are positioned within themicrocatheter 200. At the instant illustrated inFIG. 2B , theembolic implant 140 and thesoft portion 116 are protected by themicrocatheter 200 and the introducer sheath can now be pulled proximally 180 or left in place as thedelivery tube 110 andembolic implant 140 are further translated distally. -
FIGs. 3A through 3C are illustrations of an exemplary implantation system during a series of example implantation steps.FIG. 3A illustrates anembolic implant 140 and asoft portion 116 of adelivery tube 110 positioned inside amicrocatheter 200 and anintroducer sheath 180 being translated proximally over aproximal portion 118 of thedelivery tube 110. As illustrated inFIG. 3A , theintroducer sheath 180 can be disengaged from themicrocatheter 200 and pulled proximally once theembolic implant 140 andsoft section 116 are protected within themicrocatheter 200, but before theembolic implant 140 is positioned at a treatment site or within an aneurysm. Alternatively, theintroducer sheath 180 can remain engaged to the microcatheter until theembolic implant 140 is positioned at the treatment site or ready to be deployed from thedelivery tube 110 and then pulled proximally after theembolic implant 140 is positioned at the treatment site. -
FIG. 3B illustrates theintroducer sheath 180 in a deployment configuration in which theintroducer sheath 180 is engaged with aninterference feature 120 positioned near aproximal end 112 of thedelivery tube 110. Theintroducer sheath 180 is shown providing a force F against theinterference feature 120. The force can be sufficient to move theinterference feature 120 proximally in relation to thedelivery tube 110. Prior to the application of the force F, theinterference feature 120 can be detachably attached to theproximal end 112 of thedelivery tube 110, and theinterference feature 120 can be detached from theproximal end 112 of thedelivery tube 110 in response to the force F. Alternatively, theinterference feature 120 can remain attached to thedelivery tube 110 and the force F can be sufficient to move theinterference feature 120 in relation to thedelivery tube 110. - The
introducer sheath 180 can be sized to engage theinterference feature 120. As illustrated, theintroducer sheath 180 can be tubular and can have a circularproximal end 182, and theinterference feature 120 can protrude radially beyond a circumference of thedelivery tube 110. The interference feature 120 can be circular, having a circumference larger than a circumference of theproximal end 182 of theintroducer sheath 180. The interference feature 120 can provide a flat surface against which theproximal end 182 of theintroducer sheath 180 can press. Additionally, or alternatively, the interference feature can have a non-flat surface that can have a slope or a groove for receiving theintroducer sheath 180. The interference feature 120 can be a bump positioned near the distal end of the delivery tube that extends beyond the circumference of the delivery tube and extends so that theintroducer sheath 180, when slid proximally over thedelivery tube 110, must engage the interreference feature 120 before sliding completely over and off theproximal end 112 of thedelivery tube 110. -
FIG. 3C illustrates theinterference feature 120 after being moved proximally in relation to thedelivery tube 110 in response to the force F from theintroducer sheath 180. The interference feature 120 can be attached to apull wire 130, and thepull wire 130 can be pulled proximally when theinterference feature 180 is moved proximally. The interference feature 120 can be detachably attached to thedelivery tube 110 prior to the proximal movement of theinterference feature 120, and adetachment feature 122 can be manipulated to facilitate the detachment of theinterference feature 120. Once detached, theinterference feature 120 can be pulled proximally away from thedelivery tube 110, and thepull wire 130 can be moved to exit theproximal end 112 of thedelivery tube 110 in response to the pulling of theinterference feature 120. Thepull wire 130 can be an elongated member that extends through a lumen of thedelivery tube 110 toward theembolic implant 140. Thepull wire 130 can constitute a component of a deployment system for releasing theembolic implant 140 at thedistal end 114 of thedelivery tube 110. When thepull wire 130 is pulled proximally, thepull wire 130 can initiate the deployment of theembolic implant 140. Theembolic implant 140 can be detached from thedelivery tube 110 in response to the proximal movement of thepull wire 130 in relation to thedelivery tube 110. -
FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature 122a. The implantation system can have aninterference feature 120 detachably attached to adelivery tube 110 by the breakable disconnection feature 122a. Thedelivery tube 110 can includenotches 115 that are areas in which material is removed from thedelivery tube 110. Thenotches 115 can be positioned at aproximal end 112 of thedelivery tube 110. Theproximal end 112 of thedelivery tube 110 can be attached to theinterference feature 120 by gluing, welding, or other means. Thenotches 115 can be a breakable section 122a of thedelivery tube 110. When anintroducer sheath 180 is pressed against theinterference feature 120, a force from theinterference feature 120 can cause the breakable section 122a to break, and theinterference feature 120 can then be moved proximally in relation to thedelivery tube 110. The interference feature 120 can have acircular surface 124 against which theintroducer sheath 180 can press.FIG. 4B is a cross-sectional view near a proximal end of the exemplary implantation system as indicated inFIG. 4A . -
FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature 122b. The implantation system can have adelivery tube 110 withgroove 113 cut at aproximal end 112 and aninterference feature 120 that has abump 123 or another feature that can engage thegroove 113. The interference feature 120 can be detachably attached to thedelivery tube 110 by the twist-lock disconnection feature (and/or a bayonet connector) 122b. The interference feature 120 can extend within a lumen of thedelivery tube 110 at theproximal end 112 of thedelivery tube 110 and have a bump orprotrusion 123 that can be positioned in thegroove 113 in thedelivery tube 110 to maintain the attachment between theinterference feature 120 and thedelivery tube 110. The bump orprotrusion 123 can be slid through thegroove 113 to detach the interference feature 120 from thedelivery tube 110. Thegroove 113 can be L shaped, and theinterference feature 120 can be twisted in relation to thedelivery tube 110 and then pulled proximally in relation to thedelivery tube 110 to disconnect the twist-lock disconnection feature 122b.FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated inFIG. 5A . - While
FIGs. 4A through 5B illustrate examples of aninterference feature 120 that is movable in relation to thedelivery tube 110 after detaching from thedelivery tube 110, the interference feature need not be detached, and can be movable in relation to thedelivery tube 110 without detaching.FIGs. 6A through 8C illustrate example systems wherein theinterference feature 120 remains at least partially attached to thedelivery tube 110. -
FIG. 6A illustrates an exemplary implantation system having a slidingtrack 113a and a bump orprotrusion 123a. The slidingtrack 113a can be cut from a portion of thedelivery tube 110 near theproximal end 112 of thedelivery tube 110. The interference feature 120 can have an engagement bump orprotrusion 123a that is positioned to slide within thetrack 113a. Thetrack 113a can extend along a portion of a length of thedelivery tube 110, and thebump 123a can slide within thetrack 113a, allowing theinterference feature 120 to move in a proximal direction in relation to thedelivery tube 110. Thetrack 113a can be L shaped, and theinterference feature 120 can be twisted in relation to thedelivery tube 110 and then pulled proximally in relation to thedelivery tube 110 to move theinterference feature 120 in relation to thedelivery tube 110. The interference feature 120 can be attached to apull wire 130, and the movement of theinterference feature 120 can move thepull wire 130 to deploy anembolic implant 140.FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated inFIG. 6A . -
FIG. 7A illustrates an exemplary implantation system having astretchable segment 126. The implantation system can have adelivery tube 110 with astretchable segment 126 positioned near aproximal end 112 of thedelivery tube 110. Thestretchable segment 126 can be a region of thedelivery tube 110 that has a propensity to stretch in response to a force that creates tension along a length of thedelivery tube 110 that includes thestretchable segment 126. Thestretchable segment 126 can include a coil that is compressed in an initial state as illustrated inFIG. 7A , a laser cut portion of the tube, and/or a portion of tubing having greater elasticity. Thestretchable segment 126 can extends in response to a force provided by theintroducer sheath 180 against theinterference feature 120. Thestretchable segment 126 can allow the pull wire and theinterference feature 120 to move proximally in relation to thedelivery tube 110 without theinterference feature 120 becoming disconnected from thedelivery tube 110. Thestretchable segment 126 can have a fully extended length that is determined by the material properties and/or construction of thestretchable segment 126. The fully extended length can limit the distance that theinterference feature 120 can be moved proximally in relation to thedelivery tube 110.FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated inFIG. 7A . -
FIGs. 8A through 8C illustrate an exemplary implantation system having astretchable element 126a and adetachment feature 122c. Thedisconnection feature 122c illustrated inFIGs. 8A through 8C can include notches 115B in adelivery tube 110, similar to that illustrated inFIGs. 4 and 4B . It is contemplated that other disconnection features, including the disconnection features illustrated in, and described in relation toFIGs. 1 ,3A-3C ,5, or 5B could be combined with a stretchable segment like those described herein or otherwise known. When used in combination with thestretchable segment 126a, thedisconnection feature 122c can be positioned along a length of thedelivery tube 110 at or near thestretchable segment 126a. Both thestretchable segment 126a and thedisconnection feature 122c can be positioned near theproximal end 112 of thedelivery tube 110. -
FIG. 8A illustrates thestretchable element 126a positioned within a lumen of thedelivery tube 110 near theproximal end 112 of thedelivery tube 110. InFIG. 8A , thedelivery tube 110 is illustrated cut-away to show coils of thestretchable element 126a within. In the configuration illustrated inFIG. 8A , interference feature 120 can be attached to thedelivery tube 110 via thestretchable element 126a and thedetachment feature 122c. -
FIG. 8B illustrates anintroducer sheath 180 moved proximally to engage theinterference feature 120, break thedetachment feature 122c, and begin to stretch thestretchable element 126a. Thedelivery tube 110 and theintroducer sheath 180 are shown cut-away. Apull wire 130 can be positioned within thedelivery tube 110. Thepull wire 130 can be pulled proximally as theinterference feature 120 is moved proximally. Thestretchable element 126a can be attached to theinterference feature 120 with a weld, adhesive, orother connection 125. Thestretchable element 126a can be attached to thedelivery tube 110 with a weld, adhesive, orother connection 127. After thedetachment feature 122c is detached, thestretchable element 126a can maintain an attachment between theinterference feature 120 and thedelivery tube 110. -
FIG. 8C illustrates theintroducer sheath 180 moved further proximally to move theinterference feature 120 and pullwire 130 further proximally and further stretch thestretchable element 126a. Thestretchable element 126a can have a fully extended length that is determined by the material properties and/or construction of thestretchable element 126a. The fully extended length can limit the distance that theinterference feature 120 can be moved proximally in relation to thedelivery tube 110. -
FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art. Known delivery systems are typically 200 cm long, known microcatheters are typically 165 cm long, and known introducer sheaths are typically 130 cm long. In known practices, the introducer sheath is typically removed after an embolic implant and any sensitive portions of the delivery system are inserted into the microcatheter. According to known practices, an introducer sheath cannot remain around the delivery system during the deployment step of the embolic implant because the combined length of known microcatheters and introducers is several centimeters longer than known delivery systems. It is an aspect of the present invention to size a delivery system and an introducer sheath so that the introducer sheath can remain on the delivery system through the embolic implant deployment step. In example systems presented herein, an implantation system can include a delivery system, microcatheter, and introducer sheath, wherein the delivery system is longer than the combined length of the microcatheter and the introducer sheath. - An aneurysm can be treated with an implantation system such as any of the implantation systems disclosed herein in relation to the present invention by executing some or all the following steps, not necessarily in order. An implantation system 100 having an
embolic implant 140, anintroducer sheath 180, adelivery tube 110, aninterference feature 120, and apull wire 130 can be provided. Thepull wire 130 can be affixed to theinterference feature 120. Thepull wire 130 can be positioned within a lumen of thedelivery tube 110. The interference feature 120 can be attached to aproximal end 112 of thedelivery tube 110. Theembolic implant 140 can be attached at adistal end 114 of thedelivery tube 110. Theintroducer sheath 180 can be positioned to encompass theembolic implant 140 and a first portion of thedelivery tube 110. The first portion of thedelivery tube 110 can comprise asoft section 116. The introducer sheath can be sized to have an end-to-end length that is longer by about 5 cm than a length measurable from adistal end 144 of theembolic implant 140 to aproximal end 117 of thesoft section 116. Theintroducer sheath 180 can be sized so that the end-to-end length is between about 46 cm and about 105 cm. Amicrocatheter 200 can be provided. Theintroducer sheath 180 can be positioned to engage with themicrocatheter 200 while maintaining theembolic implant 140 and the first portion of thedelivery tube 110 within theintroducer sheath 180. Theembolic implant 140 and thedelivery tube 110 can be translated distally to position theembolic implant 140 and the first portion of thedelivery tube 110 within themicrocatheter 200. Theintroducer sheath 180 can be slid proximally over thedelivery tube 110. Theintroducer sheath 180 can be pulled proximally to apply a force from theintroducer sheath 180 to theinterference feature 120. Theinterference feature 120 and thepull wire 130 can be moved proximally in relation to thedelivery tube 110 in response to the force. The interference feature 120 can be detached from thedelivery tube 110. Theembolic implant 140 can be detached from thedelivery tube 110 in response to moving theinterference feature 120 and thepull wire 130 proximally in relation to thedelivery tube 110. - The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. As described herein, the invention contemplates many variations and modifications of the implantation system and associated methods, including alternative geometries of system components, alternative materials, additional or alternative method steps, etc. These modifications would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.
- The methods described herein may be not methods for the treatment of the human or animal body by surgery or therapy. For example, the methods may be ex vivo and/or in vitro methods e.g. methods taking place in a laboratory and/or for testing.
- Embodiments
- 1. A method for treating an aneurysm comprising:
- providing an implantation system comprising an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire;
- affixing the pull wire to the interference feature;
- positioning the pull wire within a lumen of the delivery tube;
- attaching the interference feature to a proximal end of the delivery tube;
- attaching the embolic implant at a distal end of the delivery tube;
- positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube;
- sliding the introducer sheath proximally over the delivery tube;
- pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and
- moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
- 2. The method of embodiment 1
wherein the first portion of the delivery tube comprises a soft section, and
wherein a first length is measurable from a distal end of the embolic implant to a proximal end of the soft section,
the method further comprising sizing the introducer sheath to comprise a second length measurable from a distal end to a proximal end of the introducer sheath, the second length measuring greater than the first length by about 5 cm. - 3. The method of embodiment 1 or embodiment 2 further comprising sizing the introducer sheath to comprise a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
- 4. The method of any one of the preceding embodiments further comprising detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
- 5. The method of any one of the preceding embodiments further comprising detaching the interference feature from the delivery tube.
- 6. The method of any one of the preceding embodiments further comprising:
- providing a microcatheter;
- positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and
translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.
Claims (15)
- An implantation system comprising:a delivery tube comprising a lumen therethrough, a proximal end, and a distal end;an embolic coil detachably attached to the distal end of the delivery tube;an introducer sheath comprising a lumen therethrough sized to slidably receive the delivery tube and the embolic coil;an interference feature positioned approximate the proximal end of the delivery tube; andan elongated member disposed within the lumen of the delivery tube and attached to the interference feature,wherein the introducer sheath is translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube and is sized to engage the interference feature,wherein the interference feature is movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature, andwherein the elongated member is movable in relation to the delivery tube in response to a proximal movement of the interference feature.
- The system of claim 1 wherein the interference feature is detachable from the delivery tube and wherein the elongated member is movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
- The system of claim 1 or claim 2
wherein the delivery tube comprises a soft section disposed approximate the distal end of the delivery tube,
wherein a first length is measurable from a distal end of the embolic coil to a proximal end of the soft section, and
wherein the introducer sheath comprises a second length measurable from a distal end to a proximal end of the introducer sheath, the second length measuring greater than the first length by about 5 cm. - The system of claim 3 further comprising a microcatheter comprising a third length measurable from a distal end to a proximal end of the microcatheter, and wherein the delivery tube comprises a fourth length measurable from the distal end to the proximal end of the delivery tube, the fourth length measuring greater than the sum of the third length and the second length.
- The system of any one of the preceding claims wherein the introducer sheath comprises a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
- The system of any one of the preceding claims
wherein the delivery tube comprises a soft section disposed approximate the distal end of the delivery tube, and
wherein the introducer sheath is movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature. - The system of any one of the preceding claims wherein the embolic coil is detachable from the delivery tube in response to a proximal movement of the elongated member in relation to the delivery tube.
- The system of any one of the preceding claims wherein the interference feature comprises a substantially circular surface positioned to engage the proximal end of the introducer sheath.
- An implantation assembly comprising:a delivery tube comprising a lumen therethrough, a proximal end, and a distal end;an embolic implant attached to the distal end of the delivery tube;a pull wire disposed within the lumen of the delivery tube and movable to detach the embolic implant from the delivery tube;an engagement bump disposed on a proximal end of the pull wire and positioned approximate the proximal end of the delivery tube; anda tubular sheath conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, the tubular sheath sized to engage the engagement bump,
wherein the engagement bump and the pull wire are movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump. - The assembly of claim 9
wherein the delivery tube comprises a soft section extending proximally from the distal end of the delivery tube,
wherein a first length is measurable from the distal end of the embolic implant to a proximal end of the soft section, and
wherein the tubular sheath comprises a second length measurable from a distal end to a proximal end of the tubular sheath, the second length measuring greater than the first length by about 5 cm. - The assembly of claim 10 further comprising a microcatheter comprising a third length measurable from a distal end to a proximal end of the microcatheter, and wherein the delivery tube comprises a fourth length measurable from the distal end of the delivery tube to the proximal end of the delivery tube, the fourth length measuring greater than the sum of the third length and the second length.
- The assembly of any one of claims 9 to 11
wherein the delivery tube comprises a soft section extending proximally from the distal end of the delivery tube, and
wherein the tubular sheath is movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump. - The assembly of any one of claims 9 to 12 wherein the engagement bump is detachable from the delivery tube in response to the force applied by the tubular sheath.
- The assembly of any one of claims 9 to 13 wherein pull wire is movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath.
- A method for treating an aneurysm comprising:providing an implantation system comprising an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire;affixing the pull wire to the interference feature;positioning the pull wire within a lumen of the delivery tube;attaching the interference feature to a proximal end of the delivery tube;attaching the embolic implant at a distal end of the delivery tube;positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube;sliding the introducer sheath proximally over the delivery tube;pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; andmoving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/218,342 US11147562B2 (en) | 2018-12-12 | 2018-12-12 | Systems and methods for embolic implant detachment |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3666202A1 true EP3666202A1 (en) | 2020-06-17 |
EP3666202B1 EP3666202B1 (en) | 2021-11-03 |
Family
ID=68886885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19215318.7A Active EP3666202B1 (en) | 2018-12-12 | 2019-12-11 | Systems for embolic implant detachment |
Country Status (6)
Country | Link |
---|---|
US (1) | US11147562B2 (en) |
EP (1) | EP3666202B1 (en) |
JP (1) | JP7412997B2 (en) |
KR (1) | KR20200072433A (en) |
CN (1) | CN111297428A (en) |
ES (1) | ES2901928T3 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9918718B2 (en) | 2014-08-08 | 2018-03-20 | DePuy Synthes Products, Inc. | Embolic coil delivery system with retractable mechanical release mechanism |
US10806462B2 (en) | 2017-12-21 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
US11147562B2 (en) | 2018-12-12 | 2021-10-19 | DePuy Synthes Products, Inc. | Systems and methods for embolic implant detachment |
US11253265B2 (en) | 2019-06-18 | 2022-02-22 | DePuy Synthes Products, Inc. | Pull wire detachment for intravascular devices |
US11426174B2 (en) | 2019-10-03 | 2022-08-30 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant mechanical release |
US11207494B2 (en) | 2019-07-03 | 2021-12-28 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11672946B2 (en) * | 2019-09-24 | 2023-06-13 | Boston Scientific Scimed, Inc. | Protection and actuation mechanism for controlled release of implantable embolic devices |
US11376013B2 (en) | 2019-11-18 | 2022-07-05 | DePuy Synthes Products, Inc. | Implant delivery system with braid cup formation |
US11457922B2 (en) | 2020-01-22 | 2022-10-04 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11432822B2 (en) * | 2020-02-14 | 2022-09-06 | DePuy Synthes Products, Inc. | Intravascular implant deployment system |
US11951026B2 (en) | 2020-06-30 | 2024-04-09 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with flexible braid section |
CN115942908A (en) | 2020-08-21 | 2023-04-07 | 形状记忆医疗公司 | Mechanical separation system for transcatheter device |
KR20220130605A (en) * | 2021-03-18 | 2022-09-27 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | Systems and methods for embolic implant detachment |
CN114081568B (en) * | 2021-11-19 | 2022-08-30 | 心凯诺医疗科技(上海)有限公司 | Assembly comprising embolic material and delivery system therefor |
US11844490B2 (en) | 2021-12-30 | 2023-12-19 | DePuy Synthes Products, Inc. | Suture linkage for inhibiting premature embolic implant deployment |
US11937824B2 (en) | 2021-12-30 | 2024-03-26 | DePuy Synthes Products, Inc. | Implant detachment systems with a modified pull wire |
US11937825B2 (en) | 2022-03-02 | 2024-03-26 | DePuy Synthes Products, Inc. | Hook wire for preventing premature embolic implant detachment |
US11937826B2 (en) | 2022-03-14 | 2024-03-26 | DePuy Synthes Products, Inc. | Proximal link wire for preventing premature implant detachment |
US20230293184A1 (en) * | 2022-03-15 | 2023-09-21 | DePuy Synthes Products, Inc. | Interference feature for inhibiting premature embolic implant detachment |
TW202400089A (en) * | 2022-03-16 | 2024-01-01 | 美商西瑞维斯克公司 | Systems and methods for the endovascular treatment of hydrocephalus and elevated intracranial pressure |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070010850A1 (en) * | 2005-06-02 | 2007-01-11 | Keith Balgobin | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US20140277093A1 (en) * | 2013-03-14 | 2014-09-18 | Stryker Nv Operations Limited | Vaso-occlusive device delivery system |
US20150182227A1 (en) * | 2013-12-27 | 2015-07-02 | Blockade Medical, LLC | Coil system |
US20180325706A1 (en) * | 2015-01-20 | 2018-11-15 | Neurogami Medical, Inc. | Vascular implant |
Family Cites Families (213)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429408A (en) | 1967-04-25 | 1969-02-25 | Associated Spring Corp | Actuator sleeves for spring clutch |
US5484409A (en) | 1989-08-25 | 1996-01-16 | Scimed Life Systems, Inc. | Intravascular catheter and method for use thereof |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5108407A (en) | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
US5636639A (en) | 1992-02-18 | 1997-06-10 | Symbiosis Corporation | Endoscopic multiple sample bioptome with enhanced biting action |
US5263964A (en) | 1992-05-06 | 1993-11-23 | Coil Partners Ltd. | Coaxial traction detachment apparatus and method |
US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5925059A (en) | 1993-04-19 | 1999-07-20 | Target Therapeutics, Inc. | Detachable embolic coil assembly |
US5569221A (en) | 1994-07-07 | 1996-10-29 | Ep Technologies, Inc. | Catheter component bond and method |
US6273404B1 (en) | 1995-06-05 | 2001-08-14 | Scimed Life Systems, Inc. | Method of making monolithic hub and strain relief |
US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US5899935A (en) | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US6203547B1 (en) | 1997-12-19 | 2001-03-20 | Target Therapeutics, Inc. | Vaso-occlusion apparatus having a manipulable mechanical detachment joint and a method for using the apparatus |
US6113622A (en) | 1998-03-10 | 2000-09-05 | Cordis Corporation | Embolic coil hydraulic deployment system |
US6835185B2 (en) | 1998-12-21 | 2004-12-28 | Micrus Corporation | Intravascular device deployment mechanism incorporating mechanical detachment |
US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6623504B2 (en) | 2000-12-08 | 2003-09-23 | Scimed Life Systems, Inc. | Balloon catheter with radiopaque distal tip |
US7018394B2 (en) * | 2001-01-10 | 2006-03-28 | Cordis Neurovascular, Inc. | Embolic coil introducer system |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US20030195553A1 (en) | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
US7608058B2 (en) | 2002-07-23 | 2009-10-27 | Micrus Corporation | Stretch resistant therapeutic device |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US7208003B2 (en) * | 2002-09-20 | 2007-04-24 | Cordis Neurovascular, Inc. | Reattachable introducer for a medical device deployment system |
FR2853521B1 (en) * | 2003-04-10 | 2005-12-02 | Claude Mialhe | DEVICE FOR EXPANDING A VESSEL AND INTRODUCING VASCULAR IMPLANT |
US7371228B2 (en) | 2003-09-19 | 2008-05-13 | Medtronic Vascular, Inc. | Delivery of therapeutics to treat aneurysms |
US8182544B2 (en) | 2003-10-08 | 2012-05-22 | Codman & Shurtleff, Inc. | Method for placing a medical agent into a vessel of the body |
US9308382B2 (en) | 2004-06-10 | 2016-04-12 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
US20060025801A1 (en) | 2004-07-30 | 2006-02-02 | Robert Lulo | Embolic device deployment system with filament release |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
WO2006052322A2 (en) | 2004-09-22 | 2006-05-18 | Guterman Lee R | Cranial aneurysm treatment arrangement |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US20060116714A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Coupling and release devices and methods for their assembly and use |
US8425550B2 (en) | 2004-12-01 | 2013-04-23 | Boston Scientific Scimed, Inc. | Embolic coils |
US7608089B2 (en) | 2004-12-22 | 2009-10-27 | Boston Scientific Scimed, Inc. | Vaso-occlusive device having pivotable coupling |
US20060206139A1 (en) | 2005-01-19 | 2006-09-14 | Tekulve Kurt J | Vascular occlusion device |
US7985238B2 (en) | 2005-06-02 | 2011-07-26 | Codman & Shurtleff, Inc. | Embolic coil delivery system with spring wire release mechanism |
US20060276825A1 (en) | 2005-06-02 | 2006-12-07 | Vladimir Mitelberg | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7377932B2 (en) | 2005-06-02 | 2008-05-27 | Cordis Neurovascular, Inc. | Embolic coil delivery system with mechanical release mechanism |
US7811305B2 (en) | 2005-06-02 | 2010-10-12 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil delivery system with spring release mechanism |
US20060276827A1 (en) | 2005-06-02 | 2006-12-07 | Vladimir Mitelberg | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7367987B2 (en) | 2005-06-02 | 2008-05-06 | Cordis Neurovascular, Inc. | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7708755B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff Inc. | Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism |
US7371251B2 (en) | 2005-06-02 | 2008-05-13 | Cordis Neurovascular, Inc. | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US20060276830A1 (en) | 2005-06-02 | 2006-12-07 | Keith Balgobin | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US20060276833A1 (en) | 2005-06-02 | 2006-12-07 | Keith Balgobin | Stretch resistant embolic coil delivery system with spring assisted release mechanism |
US7708754B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff, Pc | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7819892B2 (en) | 2005-06-02 | 2010-10-26 | Codman & Shurtleff, Inc. | Embolic coil delivery system with spring wire release mechanism |
US7819891B2 (en) | 2005-06-02 | 2010-10-26 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil delivery system with spring release mechanism |
US7371252B2 (en) | 2005-06-02 | 2008-05-13 | Cordis Neurovascular, Inc. | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US9636115B2 (en) | 2005-06-14 | 2017-05-02 | Stryker Corporation | Vaso-occlusive delivery device with kink resistant, flexible distal end |
AU2006262447A1 (en) | 2005-06-20 | 2007-01-04 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US20070083132A1 (en) | 2005-10-11 | 2007-04-12 | Sharrow James S | Medical device coil |
US8066036B2 (en) | 2005-11-17 | 2011-11-29 | Microvention, Inc. | Three-dimensional complex coil |
US9757260B2 (en) | 2006-03-30 | 2017-09-12 | Medtronic Vascular, Inc. | Prosthesis with guide lumen |
US7766933B2 (en) | 2006-03-31 | 2010-08-03 | Codman & Shurtleff, Inc. | Stretch resistant design for embolic coils with stabilization bead |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
CA2655026C (en) | 2006-06-15 | 2016-08-02 | Microvention, Inc. | Embolization device constructed from expansible polymer |
US8062325B2 (en) | 2006-07-31 | 2011-11-22 | Codman & Shurtleff, Inc. | Implantable medical device detachment system and methods of using the same |
US8366720B2 (en) | 2006-07-31 | 2013-02-05 | Codman & Shurtleff, Inc. | Interventional medical device system having an elongation retarding portion and method of using the same |
US7901444B2 (en) | 2006-09-29 | 2011-03-08 | Codman & Shurtleff, Inc. | Embolic coil delivery system with mechanical release mechanism |
US20080306503A1 (en) | 2006-11-20 | 2008-12-11 | Boston Scientific Scimed, Inc. | Mechanically detachable vaso-occlusive device |
US8926650B2 (en) | 2006-11-20 | 2015-01-06 | Boston Scientific Scimed, Inc. | Mechanically detachable vaso-occlusive device |
WO2008074027A1 (en) | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
AU2008226694B8 (en) | 2007-03-13 | 2013-06-20 | Covidien Lp | An implant including a coil and a stretch-resistant member |
US8197442B2 (en) | 2007-04-27 | 2012-06-12 | Codman & Shurtleff, Inc. | Interventional medical device system having a slotted section and radiopaque marker and method of making the same |
EP2155077A2 (en) | 2007-05-18 | 2010-02-24 | Boston Scientific Scimed, Inc. | Medical implant detachment systems |
DE102007038446A1 (en) | 2007-08-14 | 2009-02-19 | pfm Produkte für die Medizin AG | Embolisiereinrichtung |
JP5698537B2 (en) | 2007-12-21 | 2015-04-08 | マイクロベンション インコーポレイテッド | Hydrogel filament for biomedical use |
US8974518B2 (en) | 2008-03-25 | 2015-03-10 | Medtronic Vascular, Inc. | Eversible branch stent-graft and deployment method |
EA201071225A1 (en) | 2008-04-21 | 2011-06-30 | Нфокус Ньюромедикал, Инк. | DEVICES FOR EMBOLIZATION WITH REINFORCED GRID BELON AND SUPPLY SYSTEMS |
US9572982B2 (en) | 2008-04-30 | 2017-02-21 | Medtronic, Inc. | Techniques for placing medical leads for electrical stimulation of nerve tissue |
US20090312748A1 (en) | 2008-06-11 | 2009-12-17 | Johnson Kirk L | Rotational detachment mechanism |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US9232992B2 (en) | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
EP2419166B1 (en) | 2009-04-15 | 2017-11-22 | MicroVention, Inc. | Implant delivery system |
JP2012523943A (en) | 2009-04-20 | 2012-10-11 | アチーバ メディカル リミテッド | Occlusion device delivery assembly using a mechanically interlocking coupling mechanism |
US8758423B2 (en) | 2009-06-18 | 2014-06-24 | Graftcraft I Goteborg Ab | Device and method for treating ruptured aneurysms |
WO2011038017A1 (en) | 2009-09-22 | 2011-03-31 | Penumbra, Inc. | Manual actuation system for deployment of implant |
CA2779483C (en) | 2009-11-09 | 2018-03-13 | Nfocus Neuromedical, Inc. | Braid ball embolic device features |
CN102188300B (en) * | 2010-03-02 | 2014-05-28 | 上海微创医疗器械(集团)有限公司 | Aneurismal surgical device |
BR112012025969B1 (en) | 2010-04-14 | 2021-01-05 | Microvention, Inc. | implant delivery device |
US8764811B2 (en) | 2010-04-20 | 2014-07-01 | Medtronic Vascular, Inc. | Controlled tip release stent graft delivery system and method |
US8876878B2 (en) | 2010-07-23 | 2014-11-04 | Medtronic, Inc. | Attachment mechanism for stent release |
US8616040B2 (en) | 2010-09-17 | 2013-12-31 | Medtronic Vascular, Inc. | Method of forming a drug-eluting medical device |
CN103260665B (en) | 2010-12-20 | 2015-08-19 | 微温森公司 | Polymer support and manufacture method thereof |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
US9486604B2 (en) | 2011-05-12 | 2016-11-08 | Medtronic, Inc. | Packaging and preparation tray for a delivery system |
JP6026513B2 (en) | 2011-05-13 | 2016-11-16 | スパイレーション インコーポレイテッド ディー ビー エイ オリンパス レスピラトリー アメリカ | Deployment catheter |
WO2012158668A1 (en) | 2011-05-17 | 2012-11-22 | Stryker Corporation | Method of fabricating an implantable medical device that includes one or more thin film polymer support layers |
WO2012166467A1 (en) | 2011-05-27 | 2012-12-06 | Stryker Corporation | Assembly for percutaneously inserting an implantable medical device, steering the device to a target location and deploying the device |
US8734500B2 (en) * | 2011-09-27 | 2014-05-27 | DePuy Synthes Products, LLC | Distal detachment mechanisms for vascular devices |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
KR101968885B1 (en) | 2012-03-16 | 2019-04-15 | 테루모 코퍼레이션 | Stent and stent delivery device |
US9833625B2 (en) | 2012-03-26 | 2017-12-05 | Medtronic, Inc. | Implantable medical device delivery with inner and outer sheaths |
US9717421B2 (en) | 2012-03-26 | 2017-08-01 | Medtronic, Inc. | Implantable medical device delivery catheter with tether |
US9155540B2 (en) | 2012-03-30 | 2015-10-13 | DePuy Synthes Products, Inc. | Embolic coil detachment mechanism with heating element and kicker |
US9242290B2 (en) | 2012-04-03 | 2016-01-26 | Medtronic Vascular, Inc. | Method and apparatus for creating formed elements used to make wound stents |
US9549832B2 (en) | 2012-04-26 | 2017-01-24 | Medtronic Vascular, Inc. | Apparatus and methods for filling a drug eluting medical device via capillary action |
US9700399B2 (en) | 2012-04-26 | 2017-07-11 | Medtronic Vascular, Inc. | Stopper to prevent graft material slippage in a closed web stent-graft |
US9149190B2 (en) | 2012-07-17 | 2015-10-06 | Stryker Corporation | Notification system of deviation from predefined conditions |
JP2015525653A (en) | 2012-08-13 | 2015-09-07 | マイクロベンション インコーポレイテッド | Mold removal device |
US20140058435A1 (en) | 2012-08-21 | 2014-02-27 | Donald K. Jones | Implant delivery and release system |
US9504476B2 (en) | 2012-10-01 | 2016-11-29 | Microvention, Inc. | Catheter markers |
EP2906254B1 (en) | 2012-10-15 | 2020-01-08 | Microvention, Inc. | Polymeric treatment compositions |
CN108354645A (en) | 2012-11-13 | 2018-08-03 | 柯惠有限合伙公司 | plugging device |
US9539022B2 (en) | 2012-11-28 | 2017-01-10 | Microvention, Inc. | Matter conveyance system |
WO2014089390A1 (en) | 2012-12-07 | 2014-06-12 | Medtronic, Inc. | Minimally invasive implantable neurostimulation system |
WO2014107529A2 (en) | 2013-01-03 | 2014-07-10 | Jones Donald K | Detachable coil release system and handle assembly |
US10342546B2 (en) | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
US9539382B2 (en) | 2013-03-12 | 2017-01-10 | Medtronic, Inc. | Stepped catheters with flow restrictors and infusion systems using the same |
CN105228534B (en) | 2013-03-14 | 2018-03-30 | 斯瑞克公司 | Vascular occluding device induction system |
ES2879634T3 (en) | 2013-03-14 | 2021-11-22 | Stryker Corp | Vasoocclusive device delivery system |
RU2015144005A (en) | 2013-03-14 | 2017-04-19 | ИНКЬЮМЕДКС Инк. | IMPLANTS, METHODS FOR THEIR MANUFACTURE AND DEVICE AND METHODS FOR DELIVERY OF IMPLANTS TO THE PLOT OF THE AFFECTED PATIENT VESSEL |
US9398966B2 (en) | 2013-03-15 | 2016-07-26 | Medtronic Vascular, Inc. | Welded stent and stent delivery system |
CN105142543B (en) | 2013-03-15 | 2019-06-04 | 柯惠有限合伙公司 | The conveying of Vascular implant and separating mechanism |
KR102245406B1 (en) | 2013-03-15 | 2021-04-28 | 테루모 코퍼레이션 | Embolic protection device |
US9833252B2 (en) | 2013-03-15 | 2017-12-05 | Microvention, Inc. | Multi-component obstruction removal system and method |
EP2988793B1 (en) | 2013-04-22 | 2019-01-02 | Stryker European Holdings I, LLC | Method for drug loading hydroxyapatite coated implant surfaces |
US9445928B2 (en) | 2013-05-30 | 2016-09-20 | Medtronic Vascular, Inc. | Delivery system having a single handed deployment handle for a retractable outer sheath |
US11291452B2 (en) | 2013-06-26 | 2022-04-05 | W. L. Gore & Associates, Inc. | Medical device deployment system |
US9662120B2 (en) | 2013-08-23 | 2017-05-30 | Cook Medical Technologies Llc | Detachable treatment device delivery system utilizing compression at attachment zone |
US9675782B2 (en) | 2013-10-10 | 2017-06-13 | Medtronic Vascular, Inc. | Catheter pull wire actuation mechanism |
US9795391B2 (en) | 2013-10-25 | 2017-10-24 | Medtronic Vascular, Inc. | Tissue compression device with tension limiting strap retainer |
EP3082660B1 (en) | 2013-12-20 | 2020-01-22 | Microvention, Inc. | Device delivery system |
EP3082939B1 (en) | 2013-12-20 | 2020-12-02 | MicroVention, Inc. | Delivery adapter |
US9788839B2 (en) | 2014-02-14 | 2017-10-17 | Cook Medical Technologies Llc | Stable screw-type detachment mechanism |
EP3128962B1 (en) | 2014-04-08 | 2018-05-23 | Stryker Corporation | Implant delivery system |
WO2015167997A1 (en) | 2014-04-30 | 2015-11-05 | Stryker Corporation | Implant delivery system and method of use |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
US9668898B2 (en) | 2014-07-24 | 2017-06-06 | Medtronic Vascular, Inc. | Stent delivery system having dynamic deployment and methods of manufacturing same |
RU2017105842A (en) | 2014-07-25 | 2018-08-27 | Инкьюмедкс, Инк. | COATED EMBOLIC SPIRALS |
US9918718B2 (en) | 2014-08-08 | 2018-03-20 | DePuy Synthes Products, Inc. | Embolic coil delivery system with retractable mechanical release mechanism |
US9770577B2 (en) | 2014-09-15 | 2017-09-26 | Medtronic Xomed, Inc. | Pressure relief for a catheter balloon device |
NZ728984A (en) | 2014-09-17 | 2022-08-26 | Artio Medical Inc | Expandable body device and method of use |
US9579484B2 (en) | 2014-09-19 | 2017-02-28 | Medtronic Vascular, Inc. | Sterile molded dispenser |
GB2533087B (en) | 2014-12-08 | 2018-08-08 | Cook Medical Technologies Llc | Medical implant detachment mechanism and introducer assembly |
US9692557B2 (en) | 2015-02-04 | 2017-06-27 | Stryker European Holdings I, Llc | Apparatus and methods for administering treatment within a bodily duct of a patient |
US10888331B2 (en) * | 2015-02-10 | 2021-01-12 | Boston Scientific Scimed, Inc. | Active release of embolic coils |
EP3266389A4 (en) | 2015-03-03 | 2018-11-21 | Kaneka Medix Corporation | Vascular embolization tool and production method therefor |
EP3291773A4 (en) | 2015-05-07 | 2019-05-01 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Temporary interatrial shunts |
US9717503B2 (en) | 2015-05-11 | 2017-08-01 | Covidien Lp | Electrolytic detachment for implant delivery systems |
US10398874B2 (en) | 2015-05-29 | 2019-09-03 | Covidien Lp | Catheter distal tip configuration |
US10154905B2 (en) | 2015-08-07 | 2018-12-18 | Medtronic Vascular, Inc. | System and method for deflecting a delivery catheter |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
EP3334354B1 (en) | 2015-08-11 | 2021-03-03 | Terumo Corporation | System for implant delivery |
EP3349669B1 (en) | 2015-09-18 | 2020-10-21 | Terumo Corporation | Vessel prosthesis |
WO2017049314A1 (en) | 2015-09-18 | 2017-03-23 | Microvention, Inc. | Pushable implant delivery system |
CN108260342B (en) | 2015-09-18 | 2021-07-30 | 微仙美国有限公司 | Releasable delivery system |
CN113952095A (en) | 2015-09-18 | 2022-01-21 | 微仙美国有限公司 | Implant retention, detachment and delivery system |
ES2788738T3 (en) | 2015-09-21 | 2020-10-22 | Stryker Corp | Embolectomy devices |
WO2017053287A1 (en) | 2015-09-21 | 2017-03-30 | Stryker Corporation | Embolectomy devices |
US10172632B2 (en) | 2015-09-22 | 2019-01-08 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a stabilization tube |
US10631869B2 (en) | 2015-10-06 | 2020-04-28 | Boston Scientific Scimed, Inc. | Pusher arm and ball release mechanism for embolic coils |
US10327791B2 (en) | 2015-10-07 | 2019-06-25 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon |
WO2017062383A1 (en) | 2015-10-07 | 2017-04-13 | Stryker Corporation | Multiple barrel clot removal devices |
US10786302B2 (en) | 2015-10-09 | 2020-09-29 | Medtronic, Inc. | Method for closure and ablation of atrial appendage |
US9700322B2 (en) | 2015-10-14 | 2017-07-11 | Three Rivers Medical Inc. | Mechanical embolization delivery apparatus and methods |
US10271873B2 (en) | 2015-10-26 | 2019-04-30 | Medtronic Vascular, Inc. | Sheathless guide catheter assembly |
US11090055B2 (en) | 2015-10-30 | 2021-08-17 | Incumedx Inc. | Devices and methods for delivering an implant to a vascular disorder |
US20170147765A1 (en) | 2015-11-19 | 2017-05-25 | Penumbra, Inc. | Systems and methods for treatment of stroke |
US10631946B2 (en) | 2015-11-30 | 2020-04-28 | Penumbra, Inc. | System for endoscopic intracranial procedures |
EP3386580B1 (en) | 2015-12-09 | 2023-11-01 | Medtronic Vascular Inc. | Catheter with a lumen shaped as an identification symbol |
US10159568B2 (en) | 2015-12-14 | 2018-12-25 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
US10500046B2 (en) | 2015-12-14 | 2019-12-10 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
ES2913227T3 (en) | 2015-12-30 | 2022-06-01 | Stryker Corp | embolic devices |
US20170189033A1 (en) | 2016-01-06 | 2017-07-06 | Microvention, Inc. | Occlusive Embolic Coil |
US10070950B2 (en) | 2016-02-09 | 2018-09-11 | Medtronic Vascular, Inc. | Endoluminal prosthetic assemblies, and associated systems and methods for percutaneous repair of a vascular tissue defect |
AU2017217879B9 (en) | 2016-02-10 | 2021-08-19 | Microvention, Inc. | Intravascular treatment site access |
CA3014316A1 (en) | 2016-02-10 | 2017-08-17 | Microvention, Inc. | Devices for vascular occlusion |
US10188500B2 (en) | 2016-02-12 | 2019-01-29 | Medtronic Vascular, Inc. | Stent graft with external scaffolding and method |
US10485579B2 (en) | 2016-02-25 | 2019-11-26 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
US20170258476A1 (en) | 2016-03-08 | 2017-09-14 | Terumo Kabushiki Kaisha | Blood vessel treatment method |
US20170281331A1 (en) | 2016-03-31 | 2017-10-05 | Medtronic Vascular, Inc. | Endoluminal prosthetic devices having fluid-absorbable compositions for repair of a vascular tissue defect |
EP4112111A1 (en) | 2016-03-31 | 2023-01-04 | Medtronic Vascular Inc. | Expandable introducer sheath |
US10695542B2 (en) | 2016-04-04 | 2020-06-30 | Medtronic Vascular, Inc. | Drug coated balloon |
US10252024B2 (en) | 2016-04-05 | 2019-04-09 | Stryker Corporation | Medical devices and methods of manufacturing same |
US10441407B2 (en) | 2016-04-12 | 2019-10-15 | Medtronic Vascular, Inc. | Gutter filling stent-graft and method |
US9987122B2 (en) | 2016-04-13 | 2018-06-05 | Medtronic Vascular, Inc. | Iliac branch device and method |
US10010403B2 (en) | 2016-04-18 | 2018-07-03 | Medtronic Vascular, Inc. | Stent-graft prosthesis and method of manufacture |
US20170304097A1 (en) | 2016-04-21 | 2017-10-26 | Medtronic Vascular, Inc. | Stent-graft delivery system having an inner shaft component with a loading pad or covering on a distal segment thereof for stent retention |
JP6924256B2 (en) | 2016-04-25 | 2021-08-25 | ストライカー コーポレイションStryker Corporation | Pre-installed reversing tractor thrombectomy device and method |
US10940294B2 (en) | 2016-04-25 | 2021-03-09 | Medtronic Vascular, Inc. | Balloon catheter including a drug delivery sheath |
US10517711B2 (en) | 2016-04-25 | 2019-12-31 | Medtronic Vascular, Inc. | Dissection prosthesis system and method |
EP3448278B1 (en) | 2016-04-25 | 2020-05-13 | Stryker Corporation | Inverting mechanical thrombectomy apparatus |
EP3590446B1 (en) | 2016-04-25 | 2021-01-06 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses |
US10406011B2 (en) | 2016-04-28 | 2019-09-10 | Medtronic Vascular, Inc. | Implantable medical device delivery system |
US10191615B2 (en) | 2016-04-28 | 2019-01-29 | Medtronic Navigation, Inc. | Method and apparatus for image-based navigation |
US11147952B2 (en) | 2016-04-28 | 2021-10-19 | Medtronic Vascular, Inc. | Drug coated inflatable balloon having a thermal dependent release layer |
FR3050635A1 (en) | 2016-05-02 | 2017-11-03 | Univ Strasbourg | INFLATABLE AND DETACHABLE BALLOON FOR USE IN A BODY CAVITY, TREATMENT NECESSARY AND DRAINING METHOD THEREOF |
US10292844B2 (en) | 2016-05-17 | 2019-05-21 | Medtronic Vascular, Inc. | Method for compressing a stented prosthesis |
JP6803929B2 (en) | 2016-06-01 | 2020-12-23 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Improved reinforced balloon catheter |
US10285710B2 (en) | 2016-06-01 | 2019-05-14 | DePuy Synthes Products, Inc. | Endovascular detachment system with flexible distal end and heater activated detachment |
ES2924974T3 (en) | 2016-06-03 | 2022-10-13 | Stryker Corp | Reversal Thrombectomy Apparatus |
US10646689B2 (en) | 2016-07-29 | 2020-05-12 | Cephea Valve Technologies, Inc. | Mechanical interlock for catheters |
EP3490464A4 (en) | 2016-07-29 | 2020-07-29 | Wallaby Medical, Inc. | Implant delivery systems and methods |
WO2018053314A1 (en) | 2016-09-16 | 2018-03-22 | Greg Mirigian | Occlusive implants with fiber-based release structures |
US10258492B2 (en) * | 2017-03-03 | 2019-04-16 | Cook Medical Technologies Llc | Prosthesis delivery system with axially collapsible sheath |
US10806462B2 (en) | 2017-12-21 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
US11305095B2 (en) | 2018-02-22 | 2022-04-19 | Scientia Vascular, Llc | Microfabricated catheter having an intermediate preferred bending section |
US10806461B2 (en) | 2018-04-27 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube |
US10631791B2 (en) | 2018-06-25 | 2020-04-28 | Caption Health, Inc. | Video clip selector for medical imaging and diagnosis |
WO2020093012A1 (en) | 2018-11-01 | 2020-05-07 | Terumo Corporation | Occlusion systems |
US11147562B2 (en) | 2018-12-12 | 2021-10-19 | DePuy Synthes Products, Inc. | Systems and methods for embolic implant detachment |
US11207494B2 (en) | 2019-07-03 | 2021-12-28 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
-
2018
- 2018-12-12 US US16/218,342 patent/US11147562B2/en active Active
-
2019
- 2019-12-11 ES ES19215318T patent/ES2901928T3/en active Active
- 2019-12-11 JP JP2019223476A patent/JP7412997B2/en active Active
- 2019-12-11 EP EP19215318.7A patent/EP3666202B1/en active Active
- 2019-12-11 KR KR1020190164896A patent/KR20200072433A/en active Search and Examination
- 2019-12-12 CN CN201911274761.5A patent/CN111297428A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070010850A1 (en) * | 2005-06-02 | 2007-01-11 | Keith Balgobin | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US20140277093A1 (en) * | 2013-03-14 | 2014-09-18 | Stryker Nv Operations Limited | Vaso-occlusive device delivery system |
US20150182227A1 (en) * | 2013-12-27 | 2015-07-02 | Blockade Medical, LLC | Coil system |
US20180325706A1 (en) * | 2015-01-20 | 2018-11-15 | Neurogami Medical, Inc. | Vascular implant |
Also Published As
Publication number | Publication date |
---|---|
ES2901928T3 (en) | 2022-03-24 |
EP3666202B1 (en) | 2021-11-03 |
KR20200072433A (en) | 2020-06-22 |
JP2020093099A (en) | 2020-06-18 |
JP7412997B2 (en) | 2024-01-15 |
US20200187951A1 (en) | 2020-06-18 |
US11147562B2 (en) | 2021-10-19 |
CN111297428A (en) | 2020-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3666202A1 (en) | Systems and methods for embolic implant detachment | |
US20210196281A1 (en) | Systems and methods for embolic implant detachment | |
US11826051B2 (en) | Implantable medical device detachment system with split tube and cylindrical coupling | |
US7608099B2 (en) | Medical appliance delivery apparatus and method of use | |
US20220117606A1 (en) | Pull wire detachment for intravascular devices | |
US10159489B2 (en) | Systems and methods for delivering multiple embolization coils | |
EP3865079A1 (en) | Intravascular implant deployment system | |
US20030083730A1 (en) | Loading cartridge for self-expanding stent | |
EP4059446A1 (en) | Systems and methods for embolic implant detachment | |
US20230310005A1 (en) | Systems and methods for embolic implant deployment | |
US20230200819A1 (en) | Systems and methods for embolic implant deployment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201217 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210209 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BLUMENSTYK, DAVID |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20210721 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1443277 Country of ref document: AT Kind code of ref document: T Effective date: 20211115 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019008943 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20211103 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1443277 Country of ref document: AT Kind code of ref document: T Effective date: 20211103 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2901928 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220203 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220303 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220303 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220203 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019008943 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20211231 |
|
26N | No opposition filed |
Effective date: 20220804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20211211 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20211231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20191211 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231110 Year of fee payment: 5 Ref country code: IE Payment date: 20231109 Year of fee payment: 5 Ref country code: FR Payment date: 20231108 Year of fee payment: 5 Ref country code: DE Payment date: 20231031 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240118 Year of fee payment: 5 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211103 |